| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000019157 |
| Receipt No. | R000022149 |
| Official scientific title of the study | Phase II study of Cold Snare Polypectomy for Superficial Non-Ampullary Duodenal Epithelial Tumor |
| Date of disclosure of the study information | 2015/09/29 |
| Last modified on | 2017/09/30 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | Phase II study of Cold Snare Polypectomy for Superficial Non-Ampullary Duodenal Epithelial Tumor | |
| Title of the study (Brief title) | Phase II study of Cold Snare Polypectomy for Superficial Non-Ampullary Duodenal Epithelial Tumor (D-CSP) | |
| Region |
|
|
| Condition | ||
| Condition | Superficial Non-Ampullary Duodenal Epithelial Tumor (SNADET) <= 10mm | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the safety of cold snare polypectomy (CSP) |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | Delayed perforation and bleeding |
| Key secondary outcomes | The rate of spurting bleeding just after CSP, en-block resection, R0 resection, residual tumor 3 months after CSP, adverse events |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Cold Snare Polypectomy (CSP) | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) superficial non-ampullary duodenal epithelial tumor <= 10mm
2) bulbs~3rd part of deudenum 3) one lesion 4) elevated lesion expected to remove en-block using snare 5) 20 years old and more 6) can be followed for 3 months 7) Written informed consent |
|||
| Key exclusion criteria | 1) Impossible to suspend anticoagulant or antiplatelet medications (except low-dose aspirin)
2) Infectious disease with systemic therapy indicated 3) Women during pregnancy or breast-feeding 4) Psychosis 5) Systemic steroids medication 6) History of myocardial infarction within 6 months or unstable angina pectoris within 3 weeks 7) Severe respiratory disease requiring continuous oxygen therapy 8) Uncontrollable hypertension 9) Uncontrollable diabetes millutus 10) others |
|||
| Target sample size | 19 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroyuki Ono |
| Organization | Shizuoka Cancer Center |
| Division name | Division of Endoscopy |
| Address | Shimonagakubo1007, Nagaizumi-cho, Sunto-gun, Shizuoka |
| TEL | 055-989-5222 |
| h.ono@scchr.jp | |
| Public contact | |
| Name of contact person | Kohei Takizawa |
| Organization | Shizuoka Cancer Center |
| Division name | Division of Endoscopy |
| Address | Shimonagakubo1007, Nagaizumi-cho, Sunto-gun, Shizuoka |
| TEL | 055-989-5222 |
| Homepage URL | |
| k.takizawa@scchr.jp | |
| Sponsor | |
| Institute | Division of Endoscopy, Shizuoka Cancer Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 静岡県立静岡がんセンター(静岡県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000022149 |